受强制性开放获取政策约束的文章 - Bidard FC了解详情
无法在其他位置公开访问的文章:5 篇
Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data
FC Bidard, DJ Peeters, T Fehm, F Nolé, R Gisbert-Criado, D Mavroudis, ...
The lancet oncology 15 (4), 406-414, 2014
强制性开放获取政策: Cancer Research UK, UK Medical Research Council, National Institute for …
Overall survival with circulating tumor cell count–driven choice of therapy in advanced breast cancer: A randomized trial
FC Bidard, N Kiavue, W Jacot, T Bachelot, S Dureau, H Bourgeois, ...
Journal of Clinical Oncology 42 (4), 383-389, 2024
强制性开放获取政策: National Institute of Health and Medical Research, France
Hyperprogressive disease after pembrolizumab treatment in advanced Epstein-Barr Virus–associated gastric adenocarcinoma with ERBB2 amplification
S Watson, J Cyrta, M Lefevre, JM Planchon, C Louvet, V Servois, ...
JCO Precision Oncology 5, 370-377, 2021
强制性开放获取政策: National Institute of Health and Medical Research, France
On-Chip Magnetic Extraction of Circulating Cell-Free DNA from Biological Samples
K Perez-Toralla, I Pereiro, S Garrigou, F Di Federico, M Araya-Farias, ...
Microfluidics Diagnostics: Methods and Protocols, 65-75, 2024
强制性开放获取政策: National Institute of Health and Medical Research, France, European …
Imlunestrant with or without Abemaciclib in Advanced Breast Cancer
KL Jhaveri, P Neven, ML Casalnuovo, SB Kim, E Tokunaga, P Aftimos, ...
New England Journal of Medicine, 2024
强制性开放获取政策: Agence Nationale de la Recherche
可在其他位置公开访问的文章:48 篇
Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle
L De Mattos-Arruda, B Weigelt, J Cortes, HH Won, CKY Ng, P Nuciforo, ...
Annals of oncology 25 (9), 1729-1735, 2014
强制性开放获取政策: US National Institutes of Health
A phase II trial of abiraterone acetate plus prednisone in patients with triple-negative androgen receptor positive locally advanced or metastatic breast cancer (UCBG 12-1)
H Bonnefoi, T Grellety, O Tredan, M Saghatchian, F Dalenc, A Mailliez, ...
Annals of Oncology 27 (5), 812-818, 2016
强制性开放获取政策: National Institute of Health and Medical Research, France
Circulating tumor cells in breast cancer patients treated by neoadjuvant chemotherapy: a meta-analysis
FC Bidard, S Michiels, S Riethdorf, V Mueller, LJ Esserman, A Lucci, ...
JNCI: Journal of the National Cancer Institute 110 (6), 560-567, 2018
强制性开放获取政策: National Institute for Health Research, UK
Clinical application of circulating tumor cells in breast cancer: overview of the current interventional trials
FC Bidard, T Fehm, M Ignatiadis, JB Smerage, C Alix-Panabières, ...
Cancer and Metastasis Reviews, 1-10, 2012
强制性开放获取政策: US National Institutes of Health
The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper
M Cristofanilli, JY Pierga, J Reuben, A Rademaker, AA Davis, DJ Peeters, ...
Critical reviews in oncology/hematology 134, 39-45, 2019
强制性开放获取政策: Cancer Research UK, National Institute for Health Research, UK
Detection rate and prognostic value of circulating tumor cells and circulating tumor DNA in metastatic uveal melanoma
FC Bidard, J Madic, P Mariani, S Piperno‐Neumann, A Rampanou, ...
International journal of cancer 134 (5), 1207-1213, 2014
强制性开放获取政策: European Commission
Switch to fulvestrant and palbociclib versus no switch in advanced breast cancer with rising ESR1 mutation during aromatase inhibitor and palbociclib therapy (PADA-1): a …
FC Bidard, AC Hardy-Bessard, F Dalenc, T Bachelot, JY Pierga, ...
The Lancet Oncology 23 (11), 1367-1377, 2022
强制性开放获取政策: National Institute of Health and Medical Research, France
The genomic landscape of male breast cancers
S Piscuoglio, CKY Ng, MP Murray, E Guerini-Rocco, LG Martelotto, ...
Clinical Cancer Research 22 (16), 4045-4056, 2016
强制性开放获取政策: US National Institutes of Health, Susan G. Komen
A “class action” against the microenvironment: do cancer cells cooperate in metastasis?
FC Bidard, JY Pierga, A Vincent-Salomon, MF Poupon
Cancer and Metastasis Reviews 27, 5-10, 2008
强制性开放获取政策: National Institute of Health and Medical Research, France
Outlier response to anti-PD1 in uveal melanoma reveals germline MBD4 mutations in hypermutated tumors
M Rodrigues, L Mobuchon, A Houy, A Fiévet, S Gardrat, RL Barnhill, ...
Nature communications 9 (1), 1866, 2018
强制性开放获取政策: National Institute of Health and Medical Research, France, European Commission
Genetic heterogeneity in therapy-naive synchronous primary breast cancers and their metastases
CKY Ng, FC Bidard, S Piscuoglio, FC Geyer, RS Lim, I de Bruijn, R Shen, ...
Clinical cancer research 23 (15), 4402-4415, 2017
强制性开放获取政策: Swiss National Science Foundation, US National Institutes of Health
Efficacy and Determinants of Response to HER Kinase Inhibition in HER2-Mutant Metastatic Breast Cancer
LM Smyth, SA Piha-Paul, HH Won, AM Schram, C Saura, S Loi, J Lu, ...
Cancer discovery 10 (2), 198-213, 2020
强制性开放获取政策: US National Science Foundation, US National Institutes of Health, V …
Circulating tumor cells count and morphological features in breast, colorectal and prostate cancer
ST Ligthart, FAW Coumans, FC Bidard, LHJ Simkens, CJA Punt, ...
PloS one 8 (6), e67148, 2013
强制性开放获取政策: Cancer Research UK
Neutrophil extracellular traps formed during chemotherapy confer treatment resistance via TGF-β activation
A Mousset, E Lecorgne, I Bourget, P Lopez, K Jenovai, J Cherfils-Vicini, ...
Cancer Cell 41 (4), 757-775. e10, 2023
强制性开放获取政策: US National Institutes of Health, Agence Nationale de la Recherche
Current and future diagnostic and treatment strategies for patients with invasive lobular breast cancer
K Van Baelen, T Geukens, M Maetens, V Tjan-Heijnen, CJ Lord, S Linn, ...
Annals of Oncology 33 (8), 769-785, 2022
强制性开放获取政策: Research Foundation (Flanders), Cancer Research UK, European Commission
出版信息和资助信息由计算机程序自动确定